SIRO Clinpharm forms alliance with VCRO, a Taiwan based CRO.
Pact enables SIRO's clients access to booming Taiwan clinical research market.
Mumbai - India, April 20, 2010 SIRO Clinpharm a Contract Research Organization (CRO) with
presence in India, Western & Central Eastern Europe, and US today announced its alliance with
Virginia Contract Research Organization Co., Ltd. (VCRO), a Taiwan based CRO.
VCRO has more than a decade’s experience in the clinical research field having started their services
in 1997, sensing the growing need of pharmaceutical companies for ICH quality clinical trials. VCRO
has full-service clinical service capabilities including EDC, IVRS and analytical laboratory services.
SIRO Clinpharm has been in the arena of contract clinical research for more than 14 years now,
conducting ICH GCP compliant clinical trials for its global clientele. Earlier this year in February, SIRO
announced forming another engagement with a Korea based CRO, DreamCIS.
"This alliance is a collaborative partnership wherein both SIRO and VCRO will draw into each others
strengths to offer enhanced services to their customers. SIRO will now be able to offer greater reach
for patient recruitment in the region" said Ajit Nair, PhD, President, SIRO, India operations.
"VCRO has extensive network in the Asia-Pacific regions including Japan, China, Singapore and
Hong Kong. This alliance helps us deliver value arising out of our clinical capabilities and geographic
location to a global set of clients", said Chun-Chun Li, Ph.D., General Manager, VCRO.
"The clinical trials market in Taiwan is an attractive destination for global pharma-biotech firms.
Taiwan offers conducive regulatory environment and trained manpower”, said Chetan Tamhankar,
PhD, Chief Executive Officer, SIRO. “With this alliance SIRO is now in a position to offer wider
geography and cost efficiencies to its existing and potential clients."